Research News and Research

RSS

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

Æterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.

13 Apr 2010

Neovasc's 2009 revenues up 94%

Neovasc Inc., today announced financial results for the year ended December 31, 2009.

13 Apr 2010

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.

13 Apr 2010

First Edition: April 13, 2010

Today's headlines highlight the Senate's procedural vote to extend COBRA subsidies, a ruling by a Massachusetts court rejecting a bid by health insurers to raise premiums and how some states are fretting over health insurance scams.

13 Apr 2010

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Woodford Reserve bourbon will celebrate the glamour and glitz of the Kentucky Derby® with the Ultimate Kentucky Derby Luxury: the world's most exclusive mint julep cup. The Woodford Reserve $1,000 Mint Julep Cup Experience will feature a collection of 73 silver cups designed by Tiffany & Co. exclusively for Woodford Reserve. Proceeds from the cups will benefit The Barnstable Brown Kentucky Diabetes & Obesity Center.

13 Apr 2010

Researchers discover two synthetic small molecule drugs to prevent death of human stem cell

Scientists at The Scripps Research Institute have solved the decade-old mystery of why human embryonic stem cells are so difficult to culture in the laboratory, providing scientists with useful new techniques and moving the field closer to the day when stem cells can be used for therapeutic purposes.

13 Apr 2010

Sigma Life Science announces latest version of 'Your Favorite Gene Powered By Ingenuity' research portal

Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced a significant expansion to its web-based biological research portal for exploring dynamic gene-based content, Your Favorite Gene Powered By Ingenuity (http://www.wherebiobegins.com/yfg).

13 Apr 2010

Implicit association between death/ suicide and self may indicate suicide risk

Following the suicide of a relative or close friend, surviving family members and friends are left with a number of painful questions: "What made them do it?," "Why didn't they get help?" The most troublesome question is often, "Is there anything I could have done to prevent this?" People who are contemplating suicide tend to conceal their behavior, or deny they are having suicidal thoughts, so it can be difficult to identify warning signs.

13 Apr 2010

Immunomedics' progress in cancer therapy product candidates to be presented at AACR 2010

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that eight presentations reporting on the Company's progress in diverse cancer therapy product candidates will be given at the 101st Annual Meeting of the American Association for Cancer Research, April 17 – 21, 2010, in Washington, DC.

13 Apr 2010

VBL Therapeutics announces upcoming presentations at premier dermatology and cancer research meetings

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immuno-inflammatory diseases and cancer, today announced the upcoming presentations of clinical data from the company's two lead programs, VB-201 and VB-111, at premier dermatology and cancer research medical meetings this spring.

13 Apr 2010

Hospital quality needs significant improvement: 2009 Leapfrog Hospital Survey

According to new results from the 2009 Leapfrog Hospital Survey released today at the World Health Congress in Washington, DC, hospital quality needs significant improvement and waste remains rampant. One encouraging sign: steady improvements over time, supporting the value of hundreds of purchasers' growing efforts to use Leapfrog performance data in decision-making, contracting, pay for performance, and benefits design.

13 Apr 2010

Over 17,000 scientists convene at AACR 101st Annual Meeting 2010

Scientific breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when more than 17,000 scientists from around the world gather at the Walter E. Washington Convention Center, April 17-21, for the AACR 101st Annual Meeting 2010.

13 Apr 2010

AVEO Pharmaceuticals to present preclinical data from translational research platform at AACR 2010

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that preclinical data from its translational research platform and antibody pipeline will be presented during six poster sessions at the American Association for Cancer Research 101st Annual Meeting 2010 being held April 17-21, 2010, in Washington, D.C.

13 Apr 2010

High level of microRNAs found in patients with high-risk multiple myeloma

Multiple myeloma researchers at the University of Arkansas for Medical Sciences (UAMS) recently discovered that widespread activity of a specific class of genes can identify aggressive, or high-risk, cases of the disease.

13 Apr 2010

Investment report on Rexahn Pharmaceuticals

StockPreacher.com announces an investment report featuring Rexahn Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

13 Apr 2010

Health care professionals urge Congress to support nation's chemical regulatory reform

On the eve of legislation slated to be introduced this month to reform the Toxic Substances Control Act, almost two dozen organizations representing health care professionals, along with health sector businesses sent letters to Congress urging the passage of strong reform of our nation's chemical regulatory system.

13 Apr 2010

'Mindfulness' for reducing aggressive behaviour in people with developmental disabilities

A very ancient and effective practice - mindfulness - is being given a new and surprising application. For the first time ever, mindfulness is being used to reduce the likelihood of aggressive behaviour in people with developmental disabilities as well as mental health problems.

13 Apr 2010

Circadian cell division gets disrupted due to artificial light at night

Just one "pulse" of artificial light at night disrupts circadian cell division, reveals a new study carried out by Dr. Rachel Ben-Shlomo of the University of Haifa-Oranim Department of Environmental and Evolutionary Biology along with Prof. Charalambos P. Kyriacou of the University of Leicester. "Damage to cell division is characteristic of cancer, and it is therefore important to understand the causes of this damage," notes Dr. Ben-Shlomo. The study has been published in the journal Cancer Genetics and Cytogenetics.

13 Apr 2010

BioTrends Research Group, NKF publish Special Report on patients with CKD

BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. -- both those on dialysis and those with mid-late stage chronic kidney disease -- completed a survey about living with CKD.

13 Apr 2010

'Forgotten' cells in brain cancer

Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.

13 Apr 2010

Research News and Research

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

Neovasc's 2009 revenues up 94%

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

First Edition: April 13, 2010

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Researchers discover two synthetic small molecule drugs to prevent death of human stem cell

Sigma Life Science announces latest version of 'Your Favorite Gene Powered By Ingenuity' research portal

Implicit association between death/ suicide and self may indicate suicide risk

Immunomedics' progress in cancer therapy product candidates to be presented at AACR 2010

VBL Therapeutics announces upcoming presentations at premier dermatology and cancer research meetings

Hospital quality needs significant improvement: 2009 Leapfrog Hospital Survey

Over 17,000 scientists convene at AACR 101st Annual Meeting 2010

AVEO Pharmaceuticals to present preclinical data from translational research platform at AACR 2010

High level of microRNAs found in patients with high-risk multiple myeloma

Investment report on Rexahn Pharmaceuticals

Health care professionals urge Congress to support nation's chemical regulatory reform

'Mindfulness' for reducing aggressive behaviour in people with developmental disabilities

Circadian cell division gets disrupted due to artificial light at night

BioTrends Research Group, NKF publish Special Report on patients with CKD

'Forgotten' cells in brain cancer

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence